Sex differences in age trajectories of physiological dysregulation: Inflammation, metabolic syndrome, and allostatic load

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 5, 2011, Pages 493-500

  Yang, Yang ^a   Kozloski, Michael ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b The University of Chicago   (United States)

Author keywords

Age variation; Allostatic load; Inflammation; Physiological dysregulation; Sex difference

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOSTASIS; ARTICLE; FEMALE; HUMAN; INFLAMMATION; LONGEVITY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLOSTASIS; FEMALE; HUMANS; INFLAMMATION; LONGEVITY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; SEX FACTORS;

EID: 79958291562     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr003     Document Type: Article

References (49)

1. Institute of Medicine. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academy Press; 2001.
2. Weden MM, Brown RA. Historical and life course timing of the male mortality disadvantage in Europe. Biodemography Soc Biol. 2008;53: 61-79.
3. Horiuchi, S. Postmenopausal acceleration of age-related mortality increase. J Gerontol A Biol Sci. 1997;52A:B78-B92. (Pubitemid 27034823)
4. Travato F, Lalu NM. Contribution of cause-specific mortality to changing sex differences in life expectancy: seven nations case study. Soc Biol. 1998;45:1-20. (Pubitemid 128462470)
5. Waldron I. What do we know about causes of sex differences in mortality? A review of the literature. Popul Bull. 1985;18:59-76.
6. Manton KG, Woodbury MA, Stallard E. Sex differences in human mortality and aging at late ages: the effect of mortality selection and state dynamics. Gerontologist. 1995;35:597-608.
7. Finch, CE. The Biology of Human Longevity: Inflammation, Nutrition, and Aging in the Evolution of Life Spans. Amsterdam, The Netherlands: Elsevier; 2007.
8. Hermes GL, Rosenthal L, Montag A, et al. Social isolation and the inflammatory response: sex differences in the enduring effects of a prior stressor. Am J Physiol Regul Integr Comp Physiol. 2006;290:R273-R282.
9. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397. (Pubitemid 38419992)
10. Qiao Q, Laatikainen T, Zethelius B, et al. Comparison of definitions of metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohorts. Stroke. 2009; 40:337-343.
11. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated inter-leukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512. (Pubitemid 29231100)
12. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis. 2004;173:309-314. (Pubitemid 38469801)
13. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-1250. (Pubitemid 39202340)
14. Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255-263. (Pubitemid 38375339)
15. Crimmins EM, Seeman TE. Integrating biology into the study of health disparities. Population and Development Review. 2004;30(suppl):89-107.
16. Crimmins EM, Johnston M, Hayward M, et al. Age differences in allostatic load: an index of physiological dysregulation. Exp Gerontol. 2003;38:731-723.
17. Seeman TE, McEwen BS, Rowe JW, et al. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;90(8):4770-4774.
18. Schuurs AHWM, Verheul HAM. Effects of gender and sex steroids on the immune response. J Steroid Biochem Mol Biol. 1990;35(2):157-172. (Pubitemid 20067758)
19. Washburn TC, Medearis DN Jr, Childs B. Sex differences in susceptibility to infections. Pediatrics. 1965;35:57-64.
20. Da Silva JA. Sex hormones and glucocorticoids: interactions with the immune system. Ann N Y Acad Sci. 1999;876:102-117.
21. Goran MI. Energy metabolism and obesity. Med Clin North Am. 2000;84:347-362. (Pubitemid 30176626)
22. Björntorp PA. The regulation of adipose tissue distribution in humans. Int J Obes (Lond). 1996;20:291-302.
23. Laws A, Hoen HM, Selby JV, et al. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Arterioscler Thromb Vasc Biol. 1997;17:64-71.
24. Eskes T, Haanen C. Why do women live longer than men? Eu J Obstetr Rep Biol. 2007;133:126-133. (Pubitemid 47069684)
25. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46(3):464-469. (Pubitemid 41040287)
26. Kim JK, Alley D, Seeman T, et al. Recent changes in cardiovascular risk factors among women and men. J Womens Health (Larchmt). 2006;15:734-746. (Pubitemid 44349851)
27. Lakoski SG, Cushman M, Criqui M, et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) Cohort. Am Heart J. 2006;152:593-598. (Pubitemid 44233418)
28. Loucks EB, Berkman LF, Gruenewald TL, et al. Relation of social integration to inflammatory marker concentrations in men and women 70-79 years. Am J Cardiol. 2006;97:1010-1016.
29. Halvorson DS, Johnsen SH, Mathiesen EB, et al. The association between inflammatory markers and cartoid atherosclerosis is sex dependent: the Tromso Study. Cerebrovasc Dis. 2009;27:392-397.
30. Goldman NM, Weinstein M, Cornman J, et al. Sex differentials in biological risk factors for chronic disease: estimates from population-based surveys. J Womens Health (Larchmt). 2004;13(4):393-403.
31. Seeman TE, Crimmins E, Huang M, et al. Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging. Soc Sci Med. 2004;58:1985-1997. (Pubitemid 38326977)
32. Nakamura E, Miyao K. Sex differences in human biological aging. J Gerontol A Biol Sci Med Sci. 2008;63A:936-944.
33. CDC. NHANES III and IV Documentation. http://www.cdc.gov/nchs/nhanes.htm. Accessed July 1, 2009.
34. Boronat M., Saavedra P, Varillas VF, et al. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the international diabetes Federation and the National Cholesterol Education Program. Nutr Metab Cardiovasc Dis. 2009;19(6):409-416.
35. CDC. Laboratory Procedures Used for NHANES III, 1988-1994. 1996. http://www/cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf. Accessed July 1, 2009.
36. CDC. NHANES IV Laboratory Methods, 1999-2000. http://www/cdc.gov/nchs/ methods99-00.htm. Accessed July 1, 2009.
37. Crimmins EM, Alley D, Reynolds SL, et al. Changes in biological markers of health: older Americans in the 1990s. J Gerontol A Biol Sci Med Sci. 2005;60A:1409-1413. (Pubitemid 41798447)
38. National Institute of Health. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institute of Health; 2001 (Executive Summary) (NIH Publication No. 01-3670).
39. Wasserman, L. All of Statistics: A Concise Course in Statistical Inference; New York: Springer; 2004.
40. Fried LP, Xue Q, Cappola AR, et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: Implications for etiology and treatment. J Gerontol A Biol Sci Med Sci. 2009;64A:1049-1057.
41. Yang Y, Lee LC. Dynamics and heterogeneity in the process of human frailty and aging: evidence from the U.S. older adult population. J Gerontol B Psychol Sci Soc Sci. 2010;65B:246-255.
42. Leveille SG, Penninx BWJH, Melzer M, et al. Sex differences in the prevalence of disability in old age: the dynamics of incidence, recovery, and mortality. J Gerontol Soc Sci. 2000;55B:S41-S50. (Pubitemid 30154869)
43. Ferrucci L, Guralnik JM, Simonsick E, et al. Progressive versus catastrophic disability: a longitudinal view of the disablement process. J Gerontol Med Sci. 1996;51A:M123-M130. (Pubitemid 26144670)
44. Borras C, Gambini J, Gomez-Cabrera MC, et al. 17β-oestradiol upregulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell. 2005;4: 113-118. (Pubitemid 41602744)
45. Viña J, Borras C, Gambini J, et al. Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ. 2005;23: pe17.
46. Vaupel JW, Manton KG, Stallard E. The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography. 1979;16: 439-454.
47. Reither E, Hauser R, Yang Y. Do birth cohorts matter? Age-periodcohort analyses of the obesity epidemic in the U.S. Soc Sci Med. 2009;69:1439-1448.
48. Yang Y, Land KC. Age-period-cohort analysis of repeated cross-section surveys: fixed or random effects? Soc Methods Res. 2008;36:297-232.
49. Taylor SE, Klein LC, Lewis BP, et al. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-fight. Psychol Rev. 2000;107(3):411-429.